These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1455 related articles for article (PubMed ID: 21493687)

  • 1. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting.
    Cermak T; Doyle EL; Christian M; Wang L; Zhang Y; Schmidt C; Baller JA; Somia NV; Bogdanove AJ; Voytas DF
    Nucleic Acids Res; 2011 Jul; 39(12):e82. PubMed ID: 21493687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting G with TAL effectors: a comparison of activities of TALENs constructed with NN and NK repeat variable di-residues.
    Christian ML; Demorest ZL; Starker CG; Osborn MJ; Nyquist MD; Zhang Y; Carlson DF; Bradley P; Bogdanove AJ; Voytas DF
    PLoS One; 2012; 7(9):e45383. PubMed ID: 23028976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting DNA double-strand breaks with TAL effector nucleases.
    Christian M; Cermak T; Doyle EL; Schmidt C; Zhang F; Hummel A; Bogdanove AJ; Voytas DF
    Genetics; 2010 Oct; 186(2):757-61. PubMed ID: 20660643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TAL effector nuclease (TALEN) engineering.
    Li T; Yang B
    Methods Mol Biol; 2013; 978():63-72. PubMed ID: 23423889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAL Effector-Nucleotide Targeter (TALE-NT) 2.0: tools for TAL effector design and target prediction.
    Doyle EL; Booher NJ; Standage DS; Voytas DF; Brendel VP; Vandyk JK; Bogdanove AJ
    Nucleic Acids Res; 2012 Jul; 40(Web Server issue):W117-22. PubMed ID: 22693217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modularly assembled designer TAL effector nucleases for targeted gene knockout and gene replacement in eukaryotes.
    Li T; Huang S; Zhao X; Wright DA; Carpenter S; Spalding MH; Weeks DP; Yang B
    Nucleic Acids Res; 2011 Aug; 39(14):6315-25. PubMed ID: 21459844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted mutagenesis of Arabidopsis thaliana using engineered TAL effector nucleases.
    Christian M; Qi Y; Zhang Y; Voytas DF
    G3 (Bethesda); 2013 Oct; 3(10):1697-705. PubMed ID: 23979944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assembly of Customized TAL Effectors Through Advanced ULtiMATE System.
    Yang J; Guo S; Yuan P; Wei W
    Methods Mol Biol; 2016; 1338():49-60. PubMed ID: 26443213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient TALEN construction and evaluation methods for human cell and animal applications.
    Sakuma T; Hosoi S; Woltjen K; Suzuki K; Kashiwagi K; Wada H; Ochiai H; Miyamoto T; Kawai N; Sasakura Y; Matsuura S; Okada Y; Kawahara A; Hayashi S; Yamamoto T
    Genes Cells; 2013 Apr; 18(4):315-26. PubMed ID: 23388034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAL effector specificity for base 0 of the DNA target is altered in a complex, effector- and assay-dependent manner by substitutions for the tryptophan in cryptic repeat -1.
    Doyle EL; Hummel AW; Demorest ZL; Starker CG; Voytas DF; Bradley P; Bogdanove AJ
    PLoS One; 2013; 8(12):e82120. PubMed ID: 24312634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and FokI DNA-cleavage domain.
    Li T; Huang S; Jiang WZ; Wright D; Spalding MH; Weeks DP; Yang B
    Nucleic Acids Res; 2011 Jan; 39(1):359-72. PubMed ID: 20699274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-TALEN: a web tool to design TALENs for genome engineering.
    Heigwer F; Kerr G; Walther N; Glaeser K; Pelz O; Breinig M; Boutros M
    Nucleic Acids Res; 2013 Nov; 41(20):e190. PubMed ID: 24003033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAL effectors: tools for DNA targeting.
    Jankele R; Svoboda P
    Brief Funct Genomics; 2014 Sep; 13(5):409-19. PubMed ID: 24907364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Programmable DNA-binding proteins from Burkholderia provide a fresh perspective on the TALE-like repeat domain.
    de Lange O; Wolf C; Dietze J; Elsaesser J; Morbitzer R; Lahaye T
    Nucleic Acids Res; 2014 Jun; 42(11):7436-49. PubMed ID: 24792163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the transcription activator-like effectors scaffold versatility to expand the toolbox of designer nucleases.
    Juillerat A; Beurdeley M; Valton J; Thomas S; Dubois G; Zaslavskiy M; Mikolajczak J; Bietz F; Silva GH; Duclert A; Daboussi F; Duchateau P
    BMC Mol Biol; 2014 Jul; 15():13. PubMed ID: 24997498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designer TAL effectors induce disease susceptibility and resistance to Xanthomonas oryzae pv. oryzae in rice.
    Li T; Huang S; Zhou J; Yang B
    Mol Plant; 2013 May; 6(3):781-9. PubMed ID: 23430045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mojo Hand, a TALEN design tool for genome editing applications.
    Neff KL; Argue DP; Ma AC; Lee HB; Clark KJ; Ekker SC
    BMC Bioinformatics; 2013 Jan; 14():1. PubMed ID: 23323762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breaking the code of DNA binding specificity of TAL-type III effectors.
    Boch J; Scholze H; Schornack S; Landgraf A; Hahn S; Kay S; Lahaye T; Nickstadt A; Bonas U
    Science; 2009 Dec; 326(5959):1509-12. PubMed ID: 19933107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activities and specificities of homodimeric TALENs in Saccharomyces cerevisiae.
    Aouida M; Piatek MJ; Bangarusamy DK; Mahfouz MM
    Curr Genet; 2014 May; 60(2):61-74. PubMed ID: 24081604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid and highly efficient construction of TALE-based transcriptional regulators and nucleases for genome modification.
    Li L; Piatek MJ; Atef A; Piatek A; Wibowo A; Fang X; Sabir JS; Zhu JK; Mahfouz MM
    Plant Mol Biol; 2012 Mar; 78(4-5):407-16. PubMed ID: 22271303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 73.